Vitamin D Deficiency-induced Hypertension Is Associated With Vascular Oxidative Stress and Altered Heart Gene Expression
暂无分享,去创建一个
S. Goldman | P. van de Borne | J. Argacha | F. Libert | G. Berkenboom | S. Pochet | R. Moreno‐Reyes | A. Lefort | D. Egrise | D. Fontaine
[1] S. Ishiwata,et al. Titin-based regulations of diastolic and systolic functions of mammalian cardiac muscle. , 2010, Journal of molecular and cellular cardiology.
[2] P. Vanhoutte,et al. The thromboxane/endoperoxide receptor (TP): the common villain. , 2010, Journal of cardiovascular pharmacology.
[3] H. Shimokawa. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor , 2010, Pflügers Archiv - European Journal of Physiology.
[4] J. Kroetsch,et al. Nitric oxide and coronary vascular endothelium adaptations in hypertension , 2009, Vascular health and risk management.
[5] T. Pieber,et al. Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.
[6] M. Yūksel,et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. , 2009, The Journal of clinical endocrinology and metabolism.
[7] S. Hailpern,et al. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004 , 2009, Pediatrics.
[8] Lawrence J Appel,et al. Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population , 2009, Pediatrics.
[9] S. Goldman,et al. Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults , 2009, European journal of nutrition.
[10] M. Quon,et al. Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. , 2009, Endocrinology.
[11] J. O’Keefe,et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.
[12] W. März,et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.
[13] S. Penckofer,et al. The “Sunshine Deficit” and Cardiovascular Disease , 2008, Circulation.
[14] M. Félétou,et al. Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats. , 2008, American journal of physiology. Heart and circulatory physiology.
[15] P. Borne,et al. Acute Effect of Sidestream Cigarette Smoke Extract on Vascular Endothelial Function , 2008, Journal of cardiovascular pharmacology.
[16] P. Vanhoutte,et al. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. , 2008, American journal of physiology. Heart and circulatory physiology.
[17] B. Boehm,et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.
[18] J. Sugden,et al. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[19] Michael J. Pencina,et al. Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.
[20] N. Chiamvimonvat,et al. Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility , 2007, Proceedings of the National Academy of Sciences.
[21] G. London,et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.
[22] M. Aldea,et al. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. , 2006, Kidney international.
[23] G. Jagatheesan,et al. Targeted Overexpression of Sarcolipin in the Mouse Heart Decreases Sarcoplasmic Reticulum Calcium Transport and Cardiac Contractility* , 2006, Journal of Biological Chemistry.
[24] R. Koerfer,et al. Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.
[25] Richard T. Lee,et al. Hyperglycemia Promotes Oxidative Stress through Inhibition of Thioredoxin Function by Thioredoxin-interacting Protein* , 2004, Journal of Biological Chemistry.
[26] Richard T. Lee,et al. Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity , 2004, Circulation.
[27] I. Fleming. Cytochrome P450 epoxygenases as EDHF synthase(s). , 2004, Pharmacological research.
[28] M. Holick,et al. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.
[29] C. Dessy,et al. Chronic Hydroxymethylglutaryl Coenzyme A Reductase Inhibition and Endothelial Function of the Normocholesterolemic Rat: Comparison With Angiotensin-Converting Enzyme Inhibition , 2002, Journal of cardiovascular pharmacology.
[30] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .
[31] D. Wheeler,et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.
[32] Patricia T W Cohen,et al. Protein phosphatase 1--targeted in many directions. , 2002, Journal of cell science.
[33] H. Minne,et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.
[34] T. B. Paiva,et al. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. , 1999, Hypertension.
[35] Arya M. Sharma,et al. Ultraviolet B and blood pressure , 1998, The Lancet.
[36] D. McMillan,et al. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. , 1998, Circulation research.
[37] M. Haussler,et al. Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains. , 1998, Hypertension.
[38] A. Dobson,et al. Seasons, temperature and coronary disease. , 1993, International journal of epidemiology.
[39] R. Beaglehole,et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.
[40] R. Simpson,et al. Vitamin D3 and cardiovascular function in rats. , 1987, The Journal of clinical investigation.
[41] J. V. Levy. Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR). , 1980, Prostaglandins.
[42] T. Oppé,et al. Vitamin D deficiency. , 1979, British medical journal.
[43] Guilin Qiao,et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. , 2005, American journal of physiology. Endocrinology and metabolism.
[44] H. Granzier,et al. The Giant Protein Titin A Major Player in Myocardial Mechanics , Signaling , and Disease , 2004 .
[45] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.
[46] G. Powis,et al. Properties and biological activities of thioredoxins. , 2001, Annual review of biophysics and biomolecular structure.
[47] J. Köhrle,et al. Identification by differential display PCR of the selenoprotein thioredoxin reductase as a 1α,25(OH)_2‐vitamin D_3‐responsive gene in human osteoblasts — regulation by selenite , 1998, BioFactors.
[48] J. Mironneau,et al. Potassium channel activation in vascular smooth muscle. , 1992, Advances in experimental medicine and biology.